Trial
NCT01927406
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Thyroid Eye Disease
Intervention
Prostaglandin Analog
Why stopped
Funding source unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-15